Monoclonal Antibodies (Zalgen/Tulane/TSRI/UTMB)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameMonoclonal Antibodies (Zalgen/Tulane/TSRI/UTMB)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsArenavirus infection
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesZalgen Labs LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesZalgen Labs LLCUniversity Of Texas Medical BranchThe Scripps Research Institute Inc +[4] 
Active IndicationsN/A
Inactive IndicationsArenavirus infection

Other Information

ATC CodeN/A
Related LinksN/A